Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families.
High-risk families
Melanoma
Skin Cancer
Sun exposure
Sun-related behaviors
Sunbed
Sunburn
Sunscreen use
Trends
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
23 04 2021
23 04 2021
Historique:
received:
22
10
2020
accepted:
10
02
2021
entrez:
23
4
2021
pubmed:
24
4
2021
medline:
22
5
2021
Statut:
epublish
Résumé
Individuals from melanoma-prone families have similar or reduced sun-protective behaviors compared to the general population. Studies on trends in sun-related behaviors have been temporally and geographically limited. Individuals from an international consortium of melanoma-prone families (GenoMEL) were retrospectively asked about sunscreen use, sun exposure (time spent outside), sunburns, and sunbed use at several timepoints over their lifetime. Generalized linear mixed models were used to examine the association between these outcomes and birth cohort defined by decade spans, after adjusting for covariates. A total of 2407 participants from 547 families across 17 centers were analyzed. Sunscreen use increased across subsequent birth cohorts, and although the likelihood of sunburns increased until the 1950s birth cohort, it decreased thereafter. Average sun exposure did not change across the birth cohorts, and the likelihood of sunbed use increased in more recent birth cohorts. We generally did not find any differences in sun-related behavior when comparing melanoma cases to non-cases. Melanoma cases had increased sunscreen use, decreased sun exposure, and decreased odds of sunburn and sunbed use after melanoma diagnosis compared to before diagnosis. Although sunscreen use has increased and the likelihood of sunburns has decreased in more recent birth cohorts, individuals in melanoma-prone families have not reduced their overall sun exposure and had an increased likelihood of sunbed use in more recent birth cohorts. These observations demonstrate partial improvements in melanoma prevention and suggest that additional intervention strategies may be needed to achieve optimal sun-protective behavior in melanoma-prone families.
Sections du résumé
BACKGROUND
Individuals from melanoma-prone families have similar or reduced sun-protective behaviors compared to the general population. Studies on trends in sun-related behaviors have been temporally and geographically limited.
METHODS
Individuals from an international consortium of melanoma-prone families (GenoMEL) were retrospectively asked about sunscreen use, sun exposure (time spent outside), sunburns, and sunbed use at several timepoints over their lifetime. Generalized linear mixed models were used to examine the association between these outcomes and birth cohort defined by decade spans, after adjusting for covariates.
RESULTS
A total of 2407 participants from 547 families across 17 centers were analyzed. Sunscreen use increased across subsequent birth cohorts, and although the likelihood of sunburns increased until the 1950s birth cohort, it decreased thereafter. Average sun exposure did not change across the birth cohorts, and the likelihood of sunbed use increased in more recent birth cohorts. We generally did not find any differences in sun-related behavior when comparing melanoma cases to non-cases. Melanoma cases had increased sunscreen use, decreased sun exposure, and decreased odds of sunburn and sunbed use after melanoma diagnosis compared to before diagnosis.
CONCLUSIONS
Although sunscreen use has increased and the likelihood of sunburns has decreased in more recent birth cohorts, individuals in melanoma-prone families have not reduced their overall sun exposure and had an increased likelihood of sunbed use in more recent birth cohorts. These observations demonstrate partial improvements in melanoma prevention and suggest that additional intervention strategies may be needed to achieve optimal sun-protective behavior in melanoma-prone families.
Identifiants
pubmed: 33888076
doi: 10.1186/s12889-021-10424-5
pii: 10.1186/s12889-021-10424-5
pmc: PMC8063451
doi:
Substances chimiques
Sunscreening Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
692Subventions
Organisme : Sixth Framework Programme
ID : LSH-CT-2006-018702
Organisme : Cancer Research UK Programme Award
ID : C588/A4994
Organisme : Cancer Research UK Programme Award
ID : C588/ A10589
Organisme : United Kingdom Clinical Research Collaboration (GB)
ID : C8216/A6129
Organisme : NIH HHS
ID : R01 CA83115
Pays : United States
Organisme : National Health and Medical Research Council of Australia
ID : NHMRC 107359, 402761, 633004, 566946, 211172, 1093017, 1147843
Organisme : Cancer Council NSW
ID : project grant 77/00, 06/10
Organisme : Cancer Institute NSW
ID : CINSW 05/TPG/1-01, 10/TPG/1-02], 15/CDF/1-14
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2007/04313-2
Organisme : H2020 European Research Council ()
ID : ERC-2011-294576
Organisme : Spanish Fondo de Investigaciones Sanitarias
ID : PI15/00716, PI15/00956
Organisme : Catalan Government, Spain
ID : AGAUR 2014_SGR_603
Organisme : Fundació la Marató de TV3
ID : 201331-30
Organisme : Fundación Científica Asociación Española Contra el Cáncer
ID : GCB15152978SOEN
Organisme : Italian Ministry of Health
ID : RF-2016-02362288
Organisme : Consejo Nacional de Ciencia y Tecnología
ID : 152256/158706
Références
Br J Dermatol. 2020 Apr;182(4):849-859
pubmed: 31381131
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
Int J Cancer. 2002 Jan 1;97(1):90-5
pubmed: 11774248
Eur J Cancer. 2019 Sep;118:149-155
pubmed: 31349135
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):142-5
pubmed: 16434600
Am J Prev Med. 2016 Sep;51(3):e77-85
pubmed: 27067306
Br J Dermatol. 2015 Feb;172(2):475-83
pubmed: 25279754
Am J Public Health. 2020 Jun;110(6):823-828
pubmed: 32298165
Br J Dermatol. 2013 Jan;168(1):154-61
pubmed: 23039760
MMWR Morb Mortal Wkly Rep. 2012 May 11;61(18):317-22
pubmed: 22572977
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):225-235
pubmed: 28573745
PLoS Med. 2019 Oct 8;16(10):e1002932
pubmed: 31593565
Eur J Cancer. 2012 Nov;48(16):3052-62
pubmed: 22726816
World J Surg. 1992 Mar-Apr;16(2):157-65
pubmed: 1561794
J Community Health. 2018 Oct;43(5):993-1001
pubmed: 29623503
Cancer Causes Control. 2007 Apr;18(3):295-304
pubmed: 17206532
J Am Acad Dermatol. 2017 Jun;76(6):1191-1193
pubmed: 28522044
Acta Derm Venereol. 2017 Nov 15;97(10):1202-1205
pubmed: 28815267
Skinmed. 2018 Dec 21;16(6):379-383
pubmed: 30575505
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):169-77
pubmed: 25587110
Australas J Dermatol. 2017 May;58(2):111-116
pubmed: 26776445
Prog Biophys Mol Biol. 2011 Dec;107(3):349-55
pubmed: 21907230
Psychol Res Behav Manag. 2013 Dec 20;7:9-18
pubmed: 24379732
Pediatr Dermatol. 2019 May;36(3):317-323
pubmed: 30895676
JCO Glob Oncol. 2020 Apr;6:575-582
pubmed: 32293941
Qual Health Res. 2012 Jul;22(7):934-45
pubmed: 22645220
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2427-32
pubmed: 16214927
Eur J Public Health. 2012 Jun;22(3):408-12
pubmed: 22094579
J Am Acad Dermatol. 2016 Aug;75(2):371-379.e5
pubmed: 27198078
Cancer Causes Control. 2001 Jan;12(1):69-82
pubmed: 11227927
J Epidemiol. 2018 Jan 5;28(1):27-33
pubmed: 29176271
Int J Cancer. 2013 Jan 15;132(2):385-400
pubmed: 22532371
Aust N Z J Public Health. 2016 Oct;40(5):468-473
pubmed: 27523880
Cancer Causes Control. 2004 Nov;15(9):957-65
pubmed: 15577298
Aust N Z J Public Health. 2013 Feb;37(1):63-9
pubmed: 23379808
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):607-613
pubmed: 28254810
J Adolesc Health. 2012 Mar;50(3):304-7
pubmed: 22325137
Ecancermedicalscience. 2020 Mar 05;14:1017
pubmed: 32256700